SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into
Possible Breaches of Fiduciary Duty by Board of Cornerstone Therapeutics,
Inc. in Connection with Sale of Company to Chiesi Farmaceutici S.p.A.
NEW YORK -- September 16, 2013
Levi & Korsinsky is investigating the Board of Directors of Cornerstone
Therapeutics, Inc. (“Cornerstone” or the “Company”) (Nasdaq:CRTX) for possible
breaches of fiduciary duty and other violations of state law in connection
with the sale of the Company to Chiesi Farmaceutici SpA (“Chiesi”).
Click here to learn more about the investigation
http://zlk.9nl.com/cornerstone-therapeutics/, or call: 877-363-5972. There is
no cost or obligation to you.
Under the terms of the transaction, Cornerstone shareholders will receive
$9.50 for each share of Cornerstone stock they own. Chiesi currently owns 58%
of Cornerstone’s outstanding common shares. The investigation concerns, among
other things, whether the consideration to be paid to Cornerstone shareholders
is unfair, inadequate, and substantially below the fair or inherent value of
Cornerstone stock. In particular, at least one analyst set a price target for
Cornerstone stock at $14.00 per share.
If you own Cornerstone common stock and wish to obtain additional information,
please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by
telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit
Levi & Korsinsky is a national firm with offices in New York, New Jersey and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. For more information, please
feel free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
Toll Free: 877-363-5972
Press spacebar to pause and continue. Press esc to stop.